Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Published Online
on May 24, 2007

Stroke. 2007
Published online before print May 24, 2007, doi: 10.1161/STROKEAHA.106.479642
A more recent version of this article appeared on July 1, 2007
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
38/7/2063    most recent
STROKEAHA.106.479642v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ninomiya, T.
Right arrow Articles by Kiyohara, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ninomiya, T.
Right arrow Articles by Kiyohara, Y.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Metabolic Syndrome
Related Collections
Right arrow Cerebrovascular disease/stroke
Right arrow Risk Factors
Right arrow Acute myocardial infarction
Right arrow Epidemiology

Submitted on December 6, 2006
Revised on January 10, 2007
Accepted on February 2, 2007

Impact of Metabolic Syndrome on the Development of Cardiovascular Disease in a General Japanese Population. The Hisayama Study

Toshiharu Ninomiya MD, PhD*; Michiaki Kubo MD, PhD; Yasufumi Doi MD, PhD; Koji Yonemoto PhD; Yumihiro Tanizaki MD, PhD; Mahbubur Rahman MBBS, MPH, PhD; Hisatomi Arima MD, PhD; Kazuhiko Tsuryuya MD, PhD; Mitsuo Iida MD, PhD; and Yutaka Kiyohara MD, PhD

From the Departments of Environmental Medicine (T.N., M.K., K.Y., H.A., Y.K.) and Medicine and Clinical Science (Y.D., Y.T., K.T., M.I.), Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan; and the Marshfield Clinic Research Foundation (M.R.), Marshfield, Wis.

* To whom correspondence should be addressed. E-mail: nino{at}envmed.med.kyushu-u.ac.jp.

Background and Purpose--The metabolic syndrome (MetS) is associated with an increased risk of cardiovascular disease (CVD) events in general populations. However, well-designed prospective studies in Asian populations are very limited.

Methods--We prospectively evaluated a total of 2452 community-dwelling Japanese individuals aged 40 years or older from 1988 to 2002 and examined the effects of MetS defined by the modified National Cholesterol Education Program Adult Treatment Panel III criteria on incident CVD.

Results--The prevalence of the MetS was 21% in men and 30% in women at baseline. During the follow up, 307 CVD events occurred. Compared with those without MetS, the age-adjusted incidence of CVD (per 1000 person-years) was significantly higher in subjects with the MetS in both men (21.8 versus 11.6, P<0.01) and women (12.9 versus 6.5, P<0.01). The risk of CVD events was significantly higher even after adjusting for the following confounding factors: age, proteinuria, electrocardiographic abnormalities, serum total cholesterol, smoking habits, alcohol intake, and regular exercise (hazard ratio, 1.86; 95% CI, 1.32 to 2.62 in men and hazard ratio, 1.70; 95% CI, 1.22 to 2.36 in women). The risk of incident CVD was found to increase with the number of components of MetS and became significantly predictive when the number of components reached 3. Similar associations were also observed when CVD was divided into coronary heart disease and stroke.

Conclusions--Our findings suggest that MetS is a significant risk factor for the development of CVD in the Japanese middle-aged population.


Key words: cardiovascular disease • epidemiology • metabolic syndrome • myocardial infarction • stroke




This article has been cited by other articles:


Home page
Diabetes CareHome page
N. Mukai, Y. Doi, T. Ninomiya, J. Hata, K. Yonemoto, M. Iwase, M. Iida, and Y. Kiyohara
Impact of Metabolic Syndrome Compared With Impaired Fasting Glucose on the Development of Type 2 Diabetes in a General Japanese Population: The Hisayama study
Diabetes Care, December 1, 2009; 32(12): 2288 - 2293.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
T. Imamura, Y. Doi, H. Arima, K. Yonemoto, J. Hata, M. Kubo, Y. Tanizaki, S. Ibayashi, M. Iida, and Y. Kiyohara
LDL Cholesterol and the Development of Stroke Subtypes and Coronary Heart Disease in a General Japanese Population: The Hisayama Study
Stroke, February 1, 2009; 40(2): 382 - 388.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
Q. Qiao, T. Laatikainen, B. Zethelius, B. Stegmayr, M. Eliasson, P. Jousilahti, and J. Tuomilehto
Comparison of Definitions of Metabolic Syndrome in Relation to the Risk of Developing Stroke and Coronary Heart Disease in Finnish and Swedish Cohorts
Stroke, February 1, 2009; 40(2): 337 - 343.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Kubo, J. Hata, Y. Doi, Y. Tanizaki, M. Iida, and Y. Kiyohara
Secular Trends in the Incidence of and Risk Factors for Ischemic Stroke and Its Subtypes in Japanese Population
Circulation, December 16, 2008; 118(25): 2672 - 2678.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
E. Oda
Definition of Metabolic Syndrome
Stroke, November 1, 2007; 38(11): e152 - e152.
[Full Text] [PDF]